USPTFS: Hepatitis B screening

Article

Published in JAMA Network, a Reaffirmation from the US Preventive Services Task Force on screening for Hepatitis B virus infection in pregnant women.

Dr. Bobby LazzaraPublished in JAMA Network a Reaffirmation from the US Preventive Services Task Force on screening for Hepatitis B virus infection in pregnant women.

The US Preventative Services Task Force commissioned a reaffirmation evidence update looking at any new evidence solid enough to institute a change in any prior recommendations.

Findings of the review indicated that serologic testing identifies the infection, and Current Interventions are effective for preventing perinatal transmission.

As a result the US Preventative Services Task Force reaffirmed its position that screening for hepatitis B virus provides substantial benefit in pregnant women and should be accomplished at their first prenatal visit.

Related Videos
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
© 2024 MJH Life Sciences

All rights reserved.